PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day
26 Febbraio 2021 - 4:00PM
Business Wire
PPD will shine a light on rare diseases –
and its commitment to rare disease research – by illuminating its
global headquarters
PPD:
WHAT:
Rare Disease Day takes place on the last
day of February because it is a month known for having a “rare”
number of days. This annual event serves to raise awareness among
the general public and decision-makers about rare diseases and
their impact on patients' lives. On and around this day, patient
organizations, health care providers and industry leaders from
countries and regions all over the world hold awareness-raising
activities. This year, PPD will illuminate the exterior of its
worldwide headquarters with Rare Disease Day colors, including
green, pink, blue and purple.
WHY:
Rare Disease Day is just one opportunity
for PPD to pause and reflect on why we are passionate about our
work in this important area of drug research and dedicated to
improving the lives of patients and families living with rare
diseases every day. It also allows PPD to help educate the general
public, both locally and globally, on rare diseases. For more
information on PPD’s commitment to rare disease research, please
visit https://www.ppd.com/therapeutic-expertise/rare-diseases.
WHEN:
Friday, Feb. 26, 2021. Illumination begins
shortly after dusk and will end at 11:30 p.m.
(Please note: Rare Disease Day officially
is observed on Feb. 28, but PPD is illuminating its headquarters on
Friday evening.)
Rain Date: Evening hours of Saturday, Feb.
27, 2021
WHERE:
PPD’s worldwide headquarters, downtown
Wilmington
929 N. Front St.
Wilmington, NC 28401
NOTE:
Media outlets gathering b-roll of the
illumination must remain on public property when filming and/or
photographing the building. No interview opportunities, either
in-person or virtual, will be offered for this event. Media outlets
may choose to use the following quote for their coverage of the
event:
“PPD is passionate about making a
difference in the lives of people living with rare diseases,” said
Wendy Buckland, vice president of PPD’s neuroscience global
therapeutic unit. “In the pandemic, Rare Disease Day looks
different this year, but PPD is committed to raising awareness in
this complex space, and our hope is that the building illumination
at our worldwide headquarters will reflect our dedication to
helping deliver life-changing therapies for patients around the
globe. Throughout the pandemic and across the company, PPD has been
able to implement the right solutions, such as tele-visits, to make
it easier for people to participate in clinical trials for both
rare disease and non-rare disease patients, and that is vital in
getting new medicines to market.”
For more information on Rare Disease Day,
please visit https://rarediseases.org/rare-disease-day.
About PPD
PPD is a leading global contract research
organization providing comprehensive, integrated drug development,
laboratory and lifecycle management services. Our customers include
pharmaceutical, biotechnology, medical device, academic and
government organizations. With offices in 46 countries and more
than 26,000 professionals worldwide, PPD applies innovative
technologies, therapeutic expertise and a firm commitment to
quality to help customers bend the cost and time curve of drug
development and optimize value in delivering life-changing
therapies to improve health. For more information, visit
www.ppd.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210226005401/en/
Ned Glascock ned.glascock@ppd.com
Nadine Maeser nadine.maeser@ppd.com
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Pharmaceutical Product Developme (NASDAQ:PPDI)
Storico
Da Ott 2023 a Ott 2024